Jamie Brush

Dr. James W.
Brush, MD, is a General Partner & Portfolio Manager at Frazier Life Sciences Management LP and at Frazier Management LLC.
He joined the firm in 2016 and invests in private and public development stage biotechnology companies.
Prior to joining Frazier, he was a management consultant with the Boston Consulting Group, where he was a core member of the Healthcare Practice.
In this capacity, he led projects involving Biotechnology mergers and acquisitions, R&D, manufacturing, and business development strategy.
Dr. Brush received his M.D.
from the University of Southern California, where he was inducted into the Alpha Omega Alpha honors society, and his B.A.
from Middlebury College.
He completed his post-graduate training in Internal Medicine at Beth Israel Deaconess Medical Center in Boston.